[Federal Register Volume 62, Number 117 (Wednesday, June 18, 1997)]
[Notices]
[Pages 33093-33094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15989]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA regulatory issues.
Date and Time: The meeting will be held on July 10, 1997, 11 a.m.
to 1:45 p.m.
Location: Food and Drug Administration, Bldg. 29, conference room
121, 8800 Rockville Pike, Bethesda, MD. This meeting will be held by a
telephone conference call. A speaker telephone will be provided in the
conference room to allow public participation in the meeting.
Contact Person: Nancy T. Cherry or Denise H. Royster, Center for
Biologics Evaluation and Research (HFM-21), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12388. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The committee will discuss the intramural scientific
programs of the Laboratory of Pediatric and Respiratory Viral Diseases.
Procedure: On July 10, 1997, from 11 a.m. to 11:45 a.m., and from
12:45 p.m. to 1:45 p.m., the meeting is open to the public. Interested
persons may present data, information, or views, orally or in
[[Page 33094]]
writing, on issues pending before the committee. Written submissions
may be made to the contact person by July 3, 1997. Oral presentations
from the public will be scheduled between approximately 12:45 p.m. and
1:45 p.m. Time allotted for each presentation may be limited. Those
desiring to make formal oral presentations should notify the contact
person before July 3, 1997, and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and
addresses of proposed participants, and an indication of the
approximate time requested to make their presentation.
Closed committee deliberations: On July 10, 1997, from 11:45 a.m.
to 12:45 p.m., the meeting will be closed to permit discussion where
disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b(c)(6)). The meeting will be closed to discuss
personal information concerning individuals associated with the
research program.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: June 12, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-15989 Filed 6-17-97; 8:45 am]
BILLING CODE 4160-01-F
